What Is CBG? Cannabigerol Benefits, Effects & UK Guide
What Is CBG? Cannabigerol Benefits, Effects & UK Guide
If you know about THC and CBD, you may have started seeing another cannabinoid mentioned more often: CBG. CBG stands for cannabigerol, a naturally occurring compound found in the cannabis plant that has become an increasing focus of cannabinoid research.
CBG is non-intoxicating and is usually present in much smaller quantities than THC or CBD. Early laboratory studies and a small amount of human research have produced some interesting findings, but evidence for its medical benefits is still limited. In this guide, we look at what CBG actually is, why it’s sometimes called the “mother of cannabinoids”, how it differs from CBD and THC, what the latest research tells us and what UK medical cannabis patients should know.
Contents
What Is CBG?
CBG, or cannabigerol, is one of the many naturally occurring cannabinoids found in Cannabis sativa. Like CBD, CBG is generally described as non-intoxicating, meaning it does not produce the characteristic “high” associated with THC.
CBG is considered a minor cannabinoid because mature cannabis plants generally contain much smaller quantities of it than major cannabinoids such as THC or CBD.
That doesn’t necessarily make CBG unimportant. Researchers are increasingly interested in how minor cannabinoids interact with receptors and signalling systems throughout the body, and CBG has become one of the most studied of these lesser-known compounds.
Why Is CBG Called the Mother of Cannabinoids?
You may have seen CBG described online as the “mother of all cannabinoids”. The science behind this phrase actually relates primarily to its acidic precursor, CBGA (cannabigerolic acid).
CBGA plays a central role in the cannabis plant’s cannabinoid biosynthesis. As the plant develops, enzymes can convert CBGA into the acidic precursors of several other cannabinoids, including:
- THCA — the precursor to THC.
- CBDA — the precursor to CBD.
- CBCA — the precursor to CBC.
These acidic cannabinoids can then undergo a process called decarboxylation, producing cannabinoids such as THC, CBD and CBC.
So, technically, it’s CBGA rather than CBG itself that acts as an important precursor in the production of several major cannabinoids. This is where CBG’s popular “mother cannabinoid” nickname comes from.
How Does CBG Work in the Body?
Cannabinoids can interact with the body’s endocannabinoid system (ECS), a signalling network involved in regulating a wide range of physiological processes.
Two of the best-known parts of this system are the CB1 and CB2 cannabinoid receptors. Research suggests CBG can interact with both, although its pharmacology is different from THC.
Laboratory research has found that CBG can modulate signalling involving CB1 and CB2 receptors, including evidence that it can act as a partial agonist at CB2 receptors.
CBG also appears to interact with other biological targets outside the classical cannabinoid receptors. This is one reason researchers are interested in the compound, but much of this work remains preclinical and does not yet tell us how useful CBG may ultimately be as a medicine.
What Are the Potential Benefits of CBG?
Search online for “CBG benefits” and you’ll find claims covering everything from pain and inflammation to anxiety and neurological conditions.
The evidence isn’t currently strong enough to make most of those claims with confidence.
Laboratory and animal research has investigated CBG in areas including:
- Inflammation and inflammatory signalling.
- Pain-related pathways.
- Appetite and metabolism.
- Neurological and neuroprotective mechanisms.
- Anxiety and stress-related responses.
These findings are useful for identifying areas that deserve further study, but results from cells or animals cannot automatically be translated into proven benefits for patients.
CBG should therefore not currently be viewed as a proven treatment for these conditions. Larger, well-designed human clinical trials are needed before researchers can establish its effectiveness, appropriate doses and long-term safety.
What Does Human Research Tell Us About CBG?
Human research into CBG is still at a very early stage, but one recent study provides an interesting example of how the evidence is beginning to develop.
A 2024 double-blind, placebo-controlled crossover study investigated the acute effects of 20 mg of hemp-derived CBG in 34 healthy adults.
Researchers reported reductions in participants’ subjective ratings of anxiety and stress after CBG compared with placebo. They also found no evidence of intoxication or motor and cognitive impairment under the study conditions.
That’s interesting — but the limitations matter.
The study was small, examined a single dose and involved healthy adults rather than patients being treated for an anxiety disorder or another medical condition. The researchers themselves concluded that additional research is needed.
This is a good example of where CBG research currently stands: promising enough to investigate further, but far too early to describe CBG as an established treatment.
CBG vs CBD: What’s the Difference?
CBG and CBD are both naturally occurring cannabinoids and neither is generally associated with the intoxicating effects produced by THC.
They are not, however, interchangeable.
- CBG: Usually occurs at relatively low concentrations in mature cannabis and remains much less studied in humans.
- CBD: Is typically more abundant in CBD-dominant cannabis varieties and has been investigated much more extensively in clinical research.
- How they work: CBG and CBD have different pharmacological profiles and interact with multiple biological targets in different ways.
- Evidence: The clinical evidence base for CBD is considerably more developed than the evidence base for CBG.
It is therefore misleading to think of CBG simply as a “stronger CBD”. They are different cannabinoids with different pharmacology, and research into CBG is much less mature.
CBG vs THC: Does CBG Get You High?
CBG is not considered intoxicating in the way THC is.
THC is the principal cannabinoid responsible for the characteristic intoxicating effects associated with cannabis. It interacts strongly with CB1 receptors in the central nervous system.
CBG has a different pharmacological profile and does not appear to produce the same intoxicating effects.
If you’d like to understand THC in more detail, read our guide to prescribed THC.
Is CBG Legal in the UK?
The legal position around cannabinoid products in the UK is more complicated than simply checking their THC percentage.
You may see claims online that a cannabinoid product is automatically legal provided it contains less than 0.2% THC. This is misleading.
The Home Office guidance on cannabis, CBD and other cannabinoids explains that cannabis itself and a number of cannabinoids are controlled under UK drugs legislation. The legal position of a finished product depends on its composition and whether it meets the relevant exemptions and regulatory requirements.
The often-quoted 0.2% figure relates to varieties that may be grown under an industrial hemp cultivation licence. It is not a general rule making finished cannabinoid products legal when they contain less than 0.2% THC.
If you are buying a non-prescription cannabinoid product, don’t assume that terms such as “hemp-derived”, “THC-free” or “under 0.2% THC” automatically establish its legal status.
Is CBG Safe?
Because human research remains limited, there is still a lot we don’t know about the long-term safety of concentrated CBG products.
The small 2024 human trial described above did not find evidence of intoxication or impairment after a single 20 mg dose under the study conditions. That does not establish that all CBG products, doses or patterns of long-term use are risk-free.
Cannabinoids can also interact with medicines and biological pathways involved in drug metabolism. If you are already taking prescribed medication, adding cannabinoid products without discussing them with a healthcare professional may therefore be inappropriate.
CB1 Medical patients should tell their clinician about any cannabinoid or supplement products they are taking so these can be considered alongside their medication and medical history.
Does CBG Have a Role in Medical Cannabis?
CBG is one of many cannabinoids that can occur within the cannabis plant. Although THC and CBD remain the best-known and most extensively studied cannabinoids, researchers are increasingly examining whether minor cannabinoids contribute to the overall pharmacological profile of cannabis.
This is part of a much wider area of research into how cannabinoids, terpenes and other plant compounds may interact.
For patients, however, treatment decisions should not be based simply on finding a product containing the cannabinoid that sounds most promising online.
At CB1 Medical, medical cannabis treatment is considered in the context of your diagnosis, previous treatments, medical history, symptoms and individual response. You can learn more in our guide to what medical cannabis is and how it works.
CBG is an interesting part of the emerging cannabinoid picture, but the evidence should determine its medical role rather than marketing claims.
CBG FAQs
What Does CBG Stand For?
CBG stands for cannabigerol, a naturally occurring cannabinoid found in the cannabis plant.
What Does CBG Do?
CBG interacts with several biological targets, including cannabinoid receptors. Laboratory research has identified a number of potentially interesting effects, but human evidence remains limited and CBG has not been proven to treat the wide range of conditions sometimes claimed online.
Does CBG Get You High?
CBG is generally considered non-intoxicating and does not produce the characteristic “high” associated with THC.
Is CBG the Same as CBD?
No. CBG and CBD are separate cannabinoids with different pharmacological profiles. CBD has also been studied much more extensively in humans than CBG.
Is CBG Better Than CBD?
There is currently not enough clinical evidence to say that CBG is “better” than CBD. Claims that CBG is a stronger or superior version of CBD oversimplify two different cannabinoids.
What Are the Benefits of CBG?
Researchers are investigating CBG in areas including anxiety, inflammation, pain, appetite and neurological function. Most evidence remains preclinical, however, and considerably more human research is required before specific therapeutic benefits can be established.
Is CBG Legal in the UK?
The legal status of cannabinoid products depends on their composition and the relevant UK drug, medicine and consumer-product regulations. The frequently quoted “less than 0.2% THC” rule is not a general legal threshold for finished CBG or CBD products.
Can CBG Be Part of Medical Cannabis?
CBG can occur naturally alongside other cannabinoids in cannabis. Its importance within medical cannabis treatment is still being researched, and patients should follow their individual treatment plan rather than adding cannabinoid products based on claims made online.
Final Thoughts
CBG is one of the most interesting minor cannabinoids currently being studied. We know much more about it than we did a decade ago, and early human research is beginning to emerge.
But there is an important difference between promising research and proven treatment. Claims that CBG can treat pain, anxiety, inflammation or neurological conditions currently go further than the clinical evidence supports.
As research develops, we should gain a clearer picture of where CBG may fit within cannabinoid medicine. Until then, patients should approach bold health claims cautiously and discuss their treatment with a qualified clinician.
Could Medical Cannabis Be an Option for You?
CBG is only one part of a much wider medical cannabis picture. If you have a diagnosed condition and previous treatments haven’t provided sufficient benefit, use our free eligibility checker to see whether you may be suitable for an assessment with CB1 Medical.
